Tocqueville Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Tocqueville Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,711	Closed	-$280K	–	887
2016 Q1	$280K	Buy	1,711 +222	+15%	+$45K	﹤0.01%	742
2015 Q4	$488K	Sell	1,489 -55	-4%	-$17.9K	0.01%	664
2015 Q3	$498K	Hold	1,544	–	–	0.01%	698
2015 Q2	$615K	Buy	1,544 +111	+8%	+$47.2K	0.01%	668
2015 Q1	$706K	Buy	1,433 +344	+32%	+$133K	0.01%	642
2014 Q4	$390K	Buy	+1,089	New	+$324K	﹤0.01%	761
2014 Q3	–	Sell	-533	Closed	-$127K	–	1326
2014 Q2	$127K	Sell	533 -689	-56%	-$140K	﹤0.01%	1094
2014 Q1	$312K	Buy	1,222 +1,189	+3,603%	+$363K	﹤0.01%	690
2013 Q4	$7K	Buy	+33	New	+$5.87K	﹤0.01%	1218

Other funds holding LUMO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Tocqueville Asset Management's LUMO Position: Q2 2016 in Review

Tocqueville Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2016, closing a stake of 1,711 shares — an estimated $280K sold.

Tocqueville Asset Management first reported a position in LUMO in Q4 2013 and held it in 9 quarters. The position peaked at $706K in Q1 2015. 112 funds tracked by Wall St. Rank hold LUMO as of Q2 2016.

Tocqueville Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Tocqueville Asset Management sold 1,711 Lumos Pharma, Inc. Common Stock shares in Q2 2016, an estimated $280K.
Tocqueville Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 9 quarters.
Tocqueville Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $706K in Q1 2015.
112 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2016.

Based on Tocqueville Asset Management's 13F filing for Q2 2016, filed 29 Jul 2016.